We are live on ! Find out more
CTSO icon

Cytosorbents Corp

96 hedge funds and large institutions have $152M invested in Cytosorbents Corp in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

9% more capital invested

Capital invested by funds: $140M → $152M (+$12.5M)

2% more funds holding

Funds holding: 9496 (+2)

4% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 28

0.3% less ownership

Funds ownership: 40.71%40.41% (-0.3%)

35% less call options, than puts

Call options by funds: $1.3M | Put options by funds: $2.01M

Holders
96
Holders Change
+2
Holders Change %
+2.13%
% of All Funds
1.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
29
Reduced
28
Closed
14
Calls
$1.3M
Puts
$2.01M
Net Calls
-$705K
Net Calls Change
-$757K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
101
Principal Financial Group
Iowa
-$85K -10,611 Closed
SIC
102
Salem Investment Counselors
North Carolina
-$80K -10,000 Closed
ASN
103
Advisory Services Network
Georgia
-$59K -7,380 Closed
IA
104
IFP Advisors
Florida
-$18.7K -1,967 Closed
AA
105
Ancora Advisors
Ohio
-$3K -400 Closed
S
106
SignatureFD
Georgia
-$2K -228 Closed
JCM
107
Jacobi Capital Management
Pennsylvania
-$1K -100 Closed
Federated Hermes
108
Federated Hermes
Pennsylvania
-$1K -25 Closed

CTSO Hedge Fund Activity: Q1 2021 in Review

96 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2021, worth a combined $152M — up 8.9% from $140M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CTSO positions and 14 closed out — a net gain of 2 holders — while 29 added to existing stakes and 28 trimmed.

The largest buyer was Avenir Corporation, adding an estimated $1.45M. The largest seller was Sectoral Asset Management, cutting an estimated $7.93M.

  • 96 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2021, up from 94 in Q4 2020.
  • Funds reported $152M of Cytosorbents Corp stock for Q1 2021, up 8.9% quarter-over-quarter.
  • 16 funds opened new Cytosorbents Corp positions in Q1 2021 and 14 closed out, a net change of +2 holders.
  • The largest Cytosorbents Corp buyer in Q1 2021 was Avenir Corporation, an estimated $1.45M added.
  • The largest Cytosorbents Corp seller in Q1 2021 was Sectoral Asset Management, an estimated $7.93M sold.

Based on aggregated 13F filings for Q1 2021.